305 related articles for article (PubMed ID: 19350118)
1. Protection of vascular barrier integrity by activated protein C in murine models depends on protease-activated receptor-1.
Schuepbach RA; Feistritzer C; Fernández JA; Griffin JH; Riewald M
Thromb Haemost; 2009 Apr; 101(4):724-33. PubMed ID: 19350118
[TBL] [Abstract][Full Text] [Related]
2. A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signaling.
Gleeson EM; McDonnell CJ; Soule EE; Willis Fox O; Rushe H; Rehill A; Smith OP; O'Donnell JS; Preston RJS
J Thromb Haemost; 2017 Nov; 15(11):2198-2207. PubMed ID: 28834159
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
Riewald M; Ruf W
J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
[TBL] [Abstract][Full Text] [Related]
4. PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and stroke.
Sinha RK; Wang Y; Zhao Z; Xu X; Burnier L; Gupta N; Fernández JA; Martin G; Kupriyanov S; Mosnier LO; Zlokovic BV; Griffin JH
Blood; 2018 Mar; 131(11):1163-1171. PubMed ID: 29343482
[TBL] [Abstract][Full Text] [Related]
5. Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality.
Niessen F; Furlan-Freguia C; Fernández JA; Mosnier LO; Castellino FJ; Weiler H; Rosen H; Griffin JH; Ruf W
Blood; 2009 Mar; 113(12):2859-66. PubMed ID: 19141861
[TBL] [Abstract][Full Text] [Related]
6. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46.
Mosnier LO; Sinha RK; Burnier L; Bouwens EA; Griffin JH
Blood; 2012 Dec; 120(26):5237-46. PubMed ID: 23149848
[TBL] [Abstract][Full Text] [Related]
7. Activated protein C-cleaved protease activated receptor-1 is retained on the endothelial cell surface even in the presence of thrombin.
Schuepbach RA; Feistritzer C; Brass LF; Riewald M
Blood; 2008 Mar; 111(5):2667-73. PubMed ID: 18089851
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.
Riewald M; Petrovan RJ; Donner A; Ruf W
J Endotoxin Res; 2003; 9(5):317-21. PubMed ID: 14577849
[TBL] [Abstract][Full Text] [Related]
9. FVIIa (Factor VIIa) Induces Biased Cytoprotective Signaling in Mice Through the Cleavage of PAR (Protease-Activated Receptor)-1 at Canonical Arg41 (Arginine41) Site.
Kondreddy V; Pendurthi UR; Xu X; Griffin JH; Rao LVM
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1275-1288. PubMed ID: 32212848
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects.
Schuepbach RA; Madon J; Ender M; Galli P; Riewald M
J Thromb Haemost; 2012 Aug; 10(8):1675-84. PubMed ID: 22712885
[TBL] [Abstract][Full Text] [Related]
11. BMX Represses Thrombin-PAR1-Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis.
Li Z; Yin M; Zhang H; Ni W; Pierce RW; Zhou HJ; Min W
Circ Res; 2020 Feb; 126(4):471-485. PubMed ID: 31910739
[TBL] [Abstract][Full Text] [Related]
12. Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.
Roy RV; Ardeshirylajimi A; Dinarvand P; Yang L; Rezaie AR
Blood; 2016 Oct; 128(14):1884-1893. PubMed ID: 27561318
[TBL] [Abstract][Full Text] [Related]
13. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C.
Kerschen EJ; Fernandez JA; Cooley BC; Yang XV; Sood R; Mosnier LO; Castellino FJ; Mackman N; Griffin JH; Weiler H
J Exp Med; 2007 Oct; 204(10):2439-48. PubMed ID: 17893198
[TBL] [Abstract][Full Text] [Related]
14. Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease.
Ramadas N; Lowder K; Dutton J; Trebak F; Faes C; Griffin JH; Pawlinski R; Mosnier LO; Sparkenbaugh E
Blood Adv; 2024 Jun; 8(12):3272-3283. PubMed ID: 38640339
[TBL] [Abstract][Full Text] [Related]
15. Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.
Feistritzer C; Riewald M
Blood; 2005 Apr; 105(8):3178-84. PubMed ID: 15626732
[TBL] [Abstract][Full Text] [Related]
16. Activated protein C promotes protease-activated receptor-1 cytoprotective signaling through β-arrestin and dishevelled-2 scaffolds.
Soh UJ; Trejo J
Proc Natl Acad Sci U S A; 2011 Dec; 108(50):E1372-80. PubMed ID: 22106258
[TBL] [Abstract][Full Text] [Related]
17. Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in mice.
Kerschen E; Hernandez I; Zogg M; Jia S; Hessner MJ; Fernandez JA; Griffin JH; Huettner CS; Castellino FJ; Weiler H
J Clin Invest; 2010 Sep; 120(9):3167-78. PubMed ID: 20714108
[TBL] [Abstract][Full Text] [Related]
18. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand.
Bae JS; Rezaie AR
Thromb Haemost; 2008 Jul; 100(1):101-9. PubMed ID: 18612544
[TBL] [Abstract][Full Text] [Related]
19. Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injury.
Gleeson EM; Dichiara MG; Salicio A; Quinn LM; Drakeford C; Russell SE; Walsh PT; Orbe J; Hermida J; Smith OP; O'Donnell JS; Montes R; Preston RJ
Blood; 2015 Aug; 126(7):915-9. PubMed ID: 26084674
[TBL] [Abstract][Full Text] [Related]
20. Phosphoproteomic analysis of protease-activated receptor-1 biased signaling reveals unique modulators of endothelial barrier function.
Lin Y; Wozniak JM; Grimsey NJ; Girada S; Patwardhan A; Molinar-Inglis O; Smith TH; Lapek JD; Gonzalez DJ; Trejo J
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):5039-5048. PubMed ID: 32071217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
